- In December 2023, The Allen Institute, the Chan Zuckerberg Initiative, and the University of Washington launched the Seattle Hub for Synthetic Biology. The initiative focuses on developing technologies to record cellular history over time, aiding researchers in understanding the dynamics of cells and genes in relation to health and disease, enhancing biomedical research capabilities
- In July 2023, Sumitomo Chemical Co., Ltd. and Ginkgo Bioworks expanded their biomanufacturing partnership, launching a new program aimed at developing functional chemicals using synthetic biology. This collaboration seeks to innovate in the production of chemicals through synthetic biology, leveraging cutting-edge biotechnologies to meet growing demand for sustainable and bio-based solutions
- In January 2023, The National Renewable Energy Laboratory (NREL) launched a collaborative synthetic biology project with LanzaTech, Northwestern, and Yale. The project focuses on advancing biofuel discovery technologies, combining genome engineering and machine learning to identify efficient methods for large-scale, carbon-negative production of biofuels and biochemicals, contributing to sustainable energy solutions
- In August 2021, Amyris, Inc. launched Terasana Clinical, a clean skincare brand aimed at addressing skin issues such as dryness, flaking, irritation, and redness. The brand's first product, Clear + Control Healthy Skin Serum, combines moisturizing and anti-inflammatory properties to improve skin appearance, marking the first of three anticipated brand launches by Amyris in the summer
- In April 2021, GenScript introduced its Research Lentiviral Vector Packaging Service, designed for gene editing, cell line growth, and drug discovery. This service enables scientists to customize their genetic material for high-quality lentivirus production, essential in advancing therapeutics for combating COVID-19 and other emerging viral strains by supporting the creation of functional and stable viruses
- In March 2021, Integrated DNA Technologies (IDT) unveiled its rhAmpSeq CRISPR Analysis System, an advanced tool for genome editing research. This system offers an end-to-end solution for identifying on- and off-target editing events, using IDT’s rhAmpSeq technology for highly precise sequencing on Illumina platforms. It also includes an efficient library kit and user-friendly data analysis tools
Frequently Asked Questions
The market is segmented based on Segmentation, By Tool and Technology (Tool and Technology), Applications (Medical Applications, Industrial Applications, Food and Agriculture and Environmental Applications), Product (Core Product and Enabling Product) – Industry Trends and Forecast to 2032
.
The Global Synthetic Biology Platforms Market size was valued at USD 5.23 USD Billion in 2024.
The Global Synthetic Biology Platforms Market is projected to grow at a CAGR of 18.07% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
